Sometimes triple-digit revenue growth just isn't good enough.
News & Analysis: Livongo Health Inc
Many of us want to forget this year, but investors in these three companies will be especially eager to put 2020 in the rearview mirror.
Here's why two businesses that were already successful in their own niches felt a need to come together.
Take two healthcare disruptors, add a global tailwind, and a massive addressable market, and you have the recipe for a revolutionary investment.
In both cases, over 99% of participants voted thumbs-up for the deal.
Here's why analysts are excited about the telehealth leader and its merger with Livongo that shareholders just approved.
Triple-digit revenue growth apparently wasn't enough to send shares higher when the two companies reported earnings on Wednesday.
Livongo's news of a mega merger with Teladoc made waves late this summer. Investors talking about the risks of the deal may have good reason to do so.
This game-changer has the potential to redefine how patients receive care in the United States.
Investors were frightened by the $18.5 billion price tag for Livongo, but they might be missing the most important metric for valuing the company.